Inventor · disambiguated record
Kari Alitalo
Also filed as: ALITALO KARI
72 granted patents·57 pending applications·2,585 citations·filing 1994–2024
99Inventor score
Top patents by PatentIndex Score
129 records- 0196US7855178B2Growth factor binding constructs materials and methodsVEGENICS LTD·Filed 2008·Granted Dec 21, 2010·24 cites·12 claims
- 0296US6235713B1Vascular endothelial growth factor-D (VEGF-D) polypeptidesLUDWIG INST CANCER RES·Filed 1997·Granted May 22, 2001·113 cites·16 claims
- 0396US6130071AVascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereofUNIV HELSINKI LICENSING·Filed 1997·Granted Oct 10, 2000·168 cites·29 claims
- 0496US5840693AVascular endothelial growth factor-BLUDWIG INST CANCER RES·Filed 1996·Granted Nov 24, 1998·156 cites·22 claims
- 0596US5607918AVascular endothelial growth factor-B and DNA coding thereforLUDWIG INST CANCER RES·Filed 1995·Granted Mar 4, 1997·239 cites·13 claims
- 0695US6730658B1Stimulation of lymphatic growth with an FLT4 ligandUNIV HELSINKI LICENSING·Filed 2000·Granted May 4, 2004·74 cites·15 claims
- 0795US6403088B1Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3)UNIV HELSINKI LICENSING·Filed 1996·Granted Jun 11, 2002·152 cites·6 claims
- 0895US6245530B1Receptor ligandLUDWIG INST CANCER RES·Filed 1996·Granted Jun 12, 2001·143 cites·35 claims
- 0995US6221839B1FIt4 ligand and methods of useUNIV HELSINKI LICENSING·Filed 1995·Granted Apr 24, 2001·158 cites·29 claims
- 1094US7423125B2Antibodies to VEGF-CVEGENICS LTD·Filed 2004·Granted Sep 9, 2008·39 cites·36 claims
- 1194US7122654B2Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of useUNIV HELSINKI LICENSING·Filed 2002·Granted Oct 17, 2006·33 cites·1 claims
- 1294US6645933B1Receptor ligand VEGF-CUNIV HELSINKI LICENSING·Filed 1996·Granted Nov 11, 2003·117 cites·46 claims
- 1394US6361946B1Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofLICENTIA LTD·Filed 1998·Granted Mar 26, 2002·149 cites·37 claims
- 1493US7785803B2Antibody diagnostic kits and methods of useVEGENICS LTD·Filed 2007·Granted Aug 31, 2010·14 cites·6 claims
- 1593US7034105B2FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyLUDWIG INST CANCER RES·Filed 2001·Granted Apr 25, 2006·47 cites·15 claims
- 1693US6818220B1Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereofLICENTIA LTD·Filed 2000·Granted Nov 16, 2004·40 cites·27 claims
- 1793US6689580B1Growth factorLUDWIG INST CANCER RES·Filed 1999·Granted Feb 10, 2004·59 cites·14 claims
- 1892US7422741B2VEGFR-3 fusion proteinsVEGENICS LTD·Filed 2005·Granted Sep 9, 2008·19 cites·17 claims
- 1992US7410639B2Vascular endothelial growth factor D(VEGF-D) antibodies and methods of useVEGENICS LTD·Filed 2002·Granted Aug 12, 2008·25 cites·33 claims
- 2092US5776755AFLT4, a receptor tyrosine kinaseUNIV HELSINKI LICENSING·Filed 1994·Granted Jul 7, 1998·170 cites·45 claims
- 2190US6965010B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsLUDWIG INST CANCER RES·Filed 2001·Granted Nov 15, 2005·29 cites·50 claims
- 2289US7928061B2Methods of using VEGF-D polypeptidesVEGENICS PTY LTD·Filed 2007·Granted Apr 19, 2011·6 cites·15 claims
- 2389US5928939AVascular endothelial growth factor-b and dna coding thereforLUDWIG INST CANCER RES·Filed 1995·Granted Jul 27, 1999·65 cites·29 claims
- 2488US7566566B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsVENGENICS LTD·Filed 2007·Granted Jul 28, 2009·16 cites·19 claims
- 2587US7902149B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsVEGENICS PTY LTD·Filed 2009·Granted Mar 8, 2011·7 cites·13 claims
- 2687US7829091B2Therapy targeting FLT4 (VEGER-3) expressed in blood vesselsVEGENICS LTD·Filed 2004·Granted Nov 9, 2010·10 cites·60 claims
- 2787US7662932B2Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of useVEGENICS LTD·Filed 2007·Granted Feb 16, 2010·6 cites·3 claims
- 2887US7105481B2Method for stimulating connective tissue growth or wound healingLICENTIA LTD·Filed 2002·Granted Sep 12, 2006·16 cites·8 claims
- 2987US6331301B1Antibodies specific for vascular endothelial growth factor-BLUDWIG INST CANCER RES·Filed 1997·Granted Dec 18, 2001·58 cites·5 claims
- 3086US7794756B1Methods of using antibodies to VEGF-CVEGENICS LTD·Filed 2007·Granted Sep 14, 2010·5 cites·7 claims
- 3186US7709270B2Vascular endothelial growth factor C (VEGF-C) protein diagnosticVEGENICS LTD·Filed 2007·Granted May 4, 2010·5 cites·10 claims
- 3286US7309604B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsLICENTIA LTD·Filed 2005·Granted Dec 18, 2007·7 cites·86 claims
- 3385US8444957B2Methods of screening for neoplastic disease statesALITALO KARI·Filed 2010·Granted May 21, 2013·9 cites·18 claims
- 3485US7871798B2Mammalian cells that express VEGF-D polypeptidesVEGENICS LTD·Filed 2007·Granted Jan 18, 2011·3 cites·13 claims
- 3584US8278098B2Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteinsALITALO KARI·Filed 2011·Granted Oct 2, 2012·5 cites·12 claims
- 3684US8227410B2Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D)ACHEN MARC G·Filed 2011·Granted Jul 24, 2012·4 cites·12 claims
- 3784US7829536B2Method of treating lymphedema comprising administering VEGF-DVEGENICS LTD·Filed 2009·Granted Nov 9, 2010·3 cites·8 claims
- 3884US6824777B1Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyLICENTIA LTD·Filed 1998·Granted Nov 30, 2004·57 cites·54 claims
- 3984US2024368248A1Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisVEGENICS PTY LTD·Filed 2024·Application pending·0 cites
- 4082US8029984B2Materials and methods for colorectal cancer screening, diagnosis and therapyLICENTIA LTD·Filed 2004·Granted Oct 4, 2011·33 cites·22 claims
- 4182US7807412B2VEGF-C ΔR226ΔR227 mutants and uses thereofVEGENIES LTD·Filed 2007·Granted Oct 5, 2010·5 cites·13 claims
- 4282US6958147B1Use of VEGF-C to prevent restenosisLUDWIG INST CANCER RES·Filed 1999·Granted Oct 25, 2005·41 cites·27 claims
- 4382US5955291AAntibodies recognizing tie receptor tyrosine kinase and uses thereofFiled 1994·Granted Sep 21, 1999·87 cites·33 claims
- 4481US8282931B2Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofALITALO KARI·Filed 2010·Granted Oct 9, 2012·3 cites·3 claims
- 4581US7611711B2VEGFR-3 inhibitor materials and methodsVEGENICS LTD·Filed 2002·Granted Nov 3, 2009·18 cites·23 claims
- 4680US7727761B2Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofVEGENICS LTD·Filed 2004·Granted Jun 1, 2010·8 cites·17 claims
- 4780US7125714B2Progenitor cell materials and methodsLUDWIG INST CANCER RES·Filed 2002·Granted Oct 24, 2006·12 cites·17 claims
- 4878US9073997B2Growth factor antagonists for organ transplant alloimmunity and arteriosclerosisALITALO KARI·Filed 2008·Granted Jul 7, 2015·1 cites·30 claims
- 4976US7341996B2Processed vascular endothelial growth factor-B polypeptidesLUDWIG INST CANCER RES·Filed 2004·Granted Mar 11, 2008·3 cites·16 claims
- 5075US8940695B2Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapyALITALO KARI·Filed 2006·Granted Jan 27, 2015·2 cites·56 claims
Showing the top 50 of 129 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →